IDEXX Laboratories, Inc. Stock
Equities
IDXX
US45168D1046
Medical Equipment, Supplies & Distribution
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
487 USD | +1.54% | -0.46% | -12.20% |
Apr. 01 | Elanco Animal Health Appoints Two Ancora Holdings' Nominees to Board | MT |
Apr. 01 | Elanco appoints two directors after settling with activist Ancora | RE |
Financials (USD)
Sales 2024 * | 3.99B | Sales 2025 * | 4.39B | Capitalization | 39.85B |
---|---|---|---|---|---|
Net income 2024 * | 928M | Net income 2025 * | 1.05B | EV / Sales 2024 * | 10.1 x |
Net Debt 2024 * | 490M | Net Debt 2025 * | 292M | EV / Sales 2025 * | 9.13 x |
P/E ratio 2024 * |
43.1
x | P/E ratio 2025 * |
37.9
x | Employees | 11,000 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 76.52% |
Latest transcript on IDEXX Laboratories, Inc.
1 day | +0.68% | ||
1 week | -2.39% | ||
Current month | -11.18% | ||
1 month | -9.64% | ||
3 months | -9.76% | ||
6 months | +12.31% | ||
Current year | -13.60% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | 12-07-31 | |
Brian McKeon
DFI | Director of Finance/CFO | 61 | 03-06-30 |
John Hart
COO | Chief Operating Officer | - | 07-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Junius
BRD | Director/Board Member | 71 | 14-03-10 |
M. Szostak
BRD | Director/Board Member | 73 | 12-07-15 |
Chairman | 61 | 16-10-18 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
8.32% | 1 M€ | -.--% | ||
1.59% | 18 M€ | +2.56% | - | |
1.14% | 2 M€ | -1.17% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 487.4 | +1.63% | 56 167 |
24-04-22 | 479.6 | +0.68% | 419,598 |
24-04-19 | 476.4 | -0.30% | 568,646 |
24-04-18 | 477.8 | -0.09% | 399,898 |
24-04-17 | 478.2 | -2.31% | 533,305 |
Delayed Quote Nasdaq, April 22, 2024 at 04:00 pm EDT
More quotesEPS Revisions
- Stock Market
- Equities
- IDXX Stock